Cargando…
Characterization of patients with diabetes who were incidentally found to be glutamic acid decarboxylase autoantibody‐positive by bridging‐type enzyme‐linked immunosorbent assay
This study aimed to characterize diabetic patients incidentally found to be positive for glutamic acid decarboxylase autoantibodies (GADA) in general practice. Using bridging‐type enzyme‐linked immunosorbent assay, we screened 1,040 patients with phenotypic type 2 diabetes for GADA, finding 25 (2.4%...
Autores principales: | Kawasaki, Eiji, Fukuyama, Takahiro, Uchida, Aira, Sagara, Yoko, Tamai, Hidekazu, Nakano, Yuko, Tojikubo, Masayuki, Hiromatsu, Yuji, Koga, Nobuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610115/ https://www.ncbi.nlm.nih.gov/pubmed/32469160 http://dx.doi.org/10.1111/jdi.13307 |
Ejemplares similares
-
Discrepancy of glutamic acid decarboxylase 65 autoantibody results between RSR radioimmunoassay and enzyme‐linked immunosorbent assay in patients with type 1 diabetes is related to autoantibody affinity
por: Kawasaki, Eiji, et al.
Publicado: (2019) -
Efficacy of omarigliptin, once-weekly dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes
por: Kawasaki, Eiji, et al.
Publicado: (2021) -
Development of type 1 diabetes in a patient treated with anti‐interleukin‐6 receptor antibody for rheumatoid arthritis
por: Kawasaki, Eiji, et al.
Publicado: (2021) -
Statin‐induced autoimmune hepatitis in patients with type 1 diabetes: A report of two cases and literature review
por: Kawasaki, Eiji, et al.
Publicado: (2020) -
Development of Lobular Panniculitis Long After Completing the Personalized Peptide Vaccine Therapy
por: Uchida, Aira, et al.
Publicado: (2018)